Gavin Yamey MD, MPH, MA is the Director of the Center for Policy Impact in Global Health based in DGHI. The Center is an innovative policy lab that addresses critical challenges in financing and delivering global health.
He trained in clinical medicine at Oxford University and University College London, medical journalism and editing at the BMJ and public health at the London School of Hygiene and Tropical Medicine. He was Deputy Editor of the Western Journal of Medicine, Assistant Editor at the BMJ, a founding Senior Editor of PLOS Medicine, and the Principal Investigator on a $1.1 million grant from the Bill & Melinda Gates Foundation to support the launch of PLOS Neglected Tropical Diseases. In 2009, he was awarded a Kaiser Family Mini-Media Fellowship in Global Health Reporting to examine the barriers to scaling up low cost, low tech health tools in Sudan, Uganda and Kenya.
Dr. Yamey currently serves as a commissioner on two international commissions: the Lancet Commission on Tuberculosis and the Lancet Commission on Institutional Transformation for Gender and Health Equity. He previously served on two international health commissions, the Lancet Commission on Investing in Health and the Lancet Commission on Global Surgery. He has been an External Advisor to the WHO and to TDR, the Special Program for Research and Training in Tropical Diseases. Dr. Yamey has published extensively on global health, neglected diseases, health policy, and disparities in health and has been a frequent commentator on National Public Radio. He directs the Global Health Track in Duke's Program on Global Policy and Governance in Geneva.
Before joining Duke, Dr. Yamey led the Evidence-to-Policy Initiative in the Global Health Group at the University of California, San Francisco (UCSF) and was an Associate Professor of Epidemiology & Biostatistics at the UCSF School of Medicine.
Mao W, Ogbuoji O, Watkins D, Bharali I, Nsiah-Boateng E, Diab MM, et al. Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19. Plos Medicine. 2021 Jun 24;18(6):e1003675.
Wenham C, Kavanagh M, Torres I, Yamey G. Preparing for the next pandemic. Bmj (Clinical Research Ed). 2021 May 21;373:n1295.
Gonsalves G, Yamey G. The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". Bmj (Clinical Research Ed). 2021 May 17;373:n1249.